Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hogg

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The New England Journal of Medicine|June 8, 2010
Improved survival with ipilimumab in patients with metastatic melanomaF Stephen Hodi, Steven J O'Day, David F McDermott, et al.
The New England Journal of Medicine|September 12, 2017
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaJedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
Urologic Oncology|January 24, 2009
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindredPhuong L Mai, Michael Friedlander, Kathy Tucker, et al.
Genes, Chromosomes & Cancer|December 12, 2007
Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumorsRachel Linger, Darshna Dudakia, Robert Huddart, et al.
Human Molecular Genetics|January 13, 2006
Genome-wide linkage screen for testicular germ cell tumour susceptibility lociGillian P Crockford, Rachel Linger, Sarah Hockley, et al.
Journal of Medical Genetics|August 15, 2006
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsAlisa M Goldstein, May Chan, Mark Harland, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.
Cancer Research|October 19, 2006
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMELAlisa M Goldstein, May Chan, Mark Harland, et al.
American Journal of Human Genetics|December 29, 2005
The Y deletion gr/gr and susceptibility to testicular germ cell tumorKatherine L Nathanson, Peter A Kanetsky, Rachel Hawes, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The New England Journal of Medicine|June 8, 2010
Improved survival with ipilimumab in patients with metastatic melanomaF Stephen Hodi, Steven J O'Day, David F McDermott, et al.
The New England Journal of Medicine|September 12, 2017
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaJedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
Urologic Oncology|January 24, 2009
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindredPhuong L Mai, Michael Friedlander, Kathy Tucker, et al.
Genes, Chromosomes & Cancer|December 12, 2007
Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumorsRachel Linger, Darshna Dudakia, Robert Huddart, et al.
Human Molecular Genetics|January 13, 2006
Genome-wide linkage screen for testicular germ cell tumour susceptibility lociGillian P Crockford, Rachel Linger, Sarah Hockley, et al.
Journal of Medical Genetics|August 15, 2006
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsAlisa M Goldstein, May Chan, Mark Harland, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.
Cancer Research|October 19, 2006
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMELAlisa M Goldstein, May Chan, Mark Harland, et al.
American Journal of Human Genetics|December 29, 2005
The Y deletion gr/gr and susceptibility to testicular germ cell tumorKatherine L Nathanson, Peter A Kanetsky, Rachel Hawes, et al.
Pageof 8